Methotrexate-Induced Accelerated Nodulosis: A Case Series.

Q4 Medicine Mediterranean Journal of Rheumatology Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI:10.31138/mjr.08424.mia
Ramaswamy Subramanian, Nikita Chettri, Rahul Bisaralli, Purna Bansa, Mahabaleshwar Mamadapur
{"title":"Methotrexate-Induced Accelerated Nodulosis: A Case Series.","authors":"Ramaswamy Subramanian, Nikita Chettri, Rahul Bisaralli, Purna Bansa, Mahabaleshwar Mamadapur","doi":"10.31138/mjr.08424.mia","DOIUrl":null,"url":null,"abstract":"<p><p>Methotrexate-induced nodulosis, also known as methotrexate-induced accelerated nodulosis (MIAN), is a rare side effect of methotrexate therapy. Methotrexate (MTX) is commonly used to treat various autoimmune diseases, such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. In this case series, we present patients with MIAN, discussing their clinical features, diagnostic approaches, and management strategies. We aim to increase recognition of this rare side effect of MTX therapy, facilitate early diagnosis, and improve clinical management, thus minimising the burden of this debilitating complication on affected individuals.</p>","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"35 4","pages":"680-683"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11778614/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mediterranean Journal of Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31138/mjr.08424.mia","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Methotrexate-induced nodulosis, also known as methotrexate-induced accelerated nodulosis (MIAN), is a rare side effect of methotrexate therapy. Methotrexate (MTX) is commonly used to treat various autoimmune diseases, such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. In this case series, we present patients with MIAN, discussing their clinical features, diagnostic approaches, and management strategies. We aim to increase recognition of this rare side effect of MTX therapy, facilitate early diagnosis, and improve clinical management, thus minimising the burden of this debilitating complication on affected individuals.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
甲氨蝶呤引起的加速结核:一个病例系列。
甲氨蝶呤诱导的结核,也称为甲氨蝶呤诱导的加速结核(MIAN),是甲氨蝶呤治疗的罕见副作用。甲氨蝶呤(MTX)通常用于治疗各种自身免疫性疾病,如类风湿关节炎、牛皮癣和炎症性肠病。在这个病例系列中,我们介绍了MIAN患者,讨论了他们的临床特征,诊断方法和管理策略。我们的目标是提高对甲氨蝶呤治疗这种罕见副作用的认识,促进早期诊断,改善临床管理,从而最大限度地减少这种衰弱并发症对受影响个体的负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
42
审稿时长
8 weeks
期刊最新文献
Psoriatic Arthritis: Developments in 2025. Year in Review: Axial Spondyloarthritis. Psychometric Evaluation of Patients with Psoriasis and their Association with Patients' Psychological Characteristics. The Pathophysiological Significance of Dual Inhibition of IL-17A and IL-17F in Psoriatic Arthritis and Axial Spondyloarthritis. The Clinical Significance and Therapeutic Management of Dactylitis and Enthesitis in Psoriatic Arthritis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1